Furthermore, their re-examination of the Biankin dataset [ 5 ] suggested that tumors with low mutant allele frequency, when corrected for tumor cellularity, are possibly associated with better survival outcomes (though they failed to reach statistical significance in their analysis).
← all excerpts
The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma.
1
—
—